Title: A Phase I Study with an Expansion Cohort of the Combination of Ipilimumab and Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412 Arms D and E) Diefenbach, C. S., Hong, F., David, K. A., Cohen, J., Robertson, M., Advani, R., Palmisiano, N. D., Ambinder, R. F., Kahl, B. S., Ansell, S. AMER SOC HEMATOLOGY. 2016

View details for Web of Science ID 000394446803137